Staphylococcus Aureus Bacteremia Workup

Start active antimicrobial therapy promptly, identify the organism and susceptibility profile, and pursue source control in parallel rather than after culture clearance. For bacteremia management, the core actions are timely appropriately dosed antibiotics, microbiologic identification, and source control wherever feasible. BMJBMJFever and infections in surgical intensive care

Draw follow-up blood cultures within 48 hours after the initial culture set and continue cultures thereafter until the bloodstream is documented clear. A negative follow-up culture within this window is required for uncomplicated SAB; positive follow-up cultures more than 48 hours after adequate therapy identify patients at increased risk for complicated infection. BMJ+2BMJSafe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment | BMJ Opencdn clinicaltrialsProt_001.pdfcdn clinicaltrials[PDF] STUDY PROTOCOL - ClinicalTrials.gov

Immediately review all intravascular access, implanted prostheses, and sites of recent instrumentation. Remove a catheter implicated in catheter-associated SAB; source-control procedures commonly include removal of indwelling vascular access or prosthetic material, drainage of purulent collections, and debridement of osteomyelitis. cdn clinicaltrialscdn clinicaltrialsProt_001.pdf

Classify SAB as uncomplicated only when every criterion is met: endocarditis excluded by echocardiography; a catheter-associated source with catheter removal; no implanted prostheses; follow-up cultures obtained within 48 hours that remain negative; defervescence within 72 hours of effective therapy; and no metastatic infection. Any patient failing one or more criterion should be managed as complicated SAB. cdn clinicaltrialscdn clinicaltrialsProt_001.pdf

A closely related IDSA-derived definition requires negative follow-up cultures obtained 2-4 days after the initial set, defervescence within 72 hours, no prosthetic material, and no endocarditis or metastatic infection. The practical implication is conservative: short-course treatment requires documented rapid clearance and a completed complication assessment, not an apparently well patient. cdn clinicaltrialscdn clinicaltrials[PDF] STUDY PROTOCOL - ClinicalTrials.gov

Community acquisition, delayed initiation of adequate therapy, fever persisting at 72 hours, and cultures remaining positive beyond 48 hours are predictors of complicated SAB. Their presence should lower the threshold for targeted imaging and extended intravenous treatment even before a discrete metastatic site is proven. BMJBMJSafe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment | BMJ Open

Obtain echocardiographic evaluation when considering a short-course regimen because infective endocarditis is therapeutically decisive and may lack classic peripheral findings early. Reported infective endocarditis prevalence in SAB has varied from 5% to 64% across study populations, underscoring that bedside appearance is not a reliable exclusion strategy. jaccjaccRole of Echocardiography in Evaluation of Patients With <i ... - JACC

A negative TTE may not be sufficiently sensitive to rule out infective endocarditis. Historical guideline approaches have therefore recommended TEE for all patients with SAB or, if TEE is not performed, management with prolonged intravenous therapy; TEE feasibility may be limited by availability, patient refusal, or critical illness. jaccjaccUse of Transthoracic Echocardiography in the Management of Low ...

Use a negative echocardiographic evaluation as one component of a complete uncomplicated-SAB determination, not as a substitute for documenting blood-culture clearance, defervescence, lack of prosthetic material, and absence of metastatic infection. cdn clinicaltrials+1cdn clinicaltrialsProt_001.pdfcdn clinicaltrials[PDF] STUDY PROTOCOL - ClinicalTrials.gov

Direct the examination and imaging strategy to clinical findings, but do not defer source investigation in persistent SAB. Complicated SAB includes infective endocarditis, metastatic infection foci, and deep-tissue infection; persistent cultures and fever are clinical predictors that should trigger renewed examination for these entities. BMJBMJSafe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment | BMJ Open

For suspected catheter-associated SAB, determine whether the catheter is the likely source and remove it. Retained vascular devices and prosthetic material prevent uncomplicated classification; source-control procedures for SAB may include vascular-access removal, removal of infected prosthetic material, incision and drainage, and debridement of osteomyelitis. cdn clinicaltrialscdn clinicaltrialsProt_001.pdf

When a metastatic focus is identified, align duration with the focal syndrome rather than with uncomplicated bacteremia. Endocarditis and osteomyelitis are examples for which 4-6 weeks may be required, and source control remains integral to cure. BMJBMJFever and infections in surgical intensive care

For MSSA bacteremia, antistaphylococcal penicillins—nafcillin and oxacillin—are described as recommended definitive options. Cefazolin is frequently used because it is easier to administer and is associated with fewer adverse events; a large retrospective cohort found lower 30- and 90-day mortality with cefazolin than with antistaphylococcal penicillins, although observational comparisons do not resolve all regimen-selection questions. NEJMNEJMCefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Still Some Questions | NEJM Clinician

For MRSA bacteremia, intravenous vancomycin is a usual initial treatment, with daptomycin described as an alternative in renal impairment. Do not interpret persistent bacteremia as an automatic indication for prolonged monotherapy: verify active therapy, remove or drain the source, evaluate for endocarditis and deep infection, and obtain serial cultures until clearance. BMJ+2BMJFever and infections in surgical intensive carecellMethicillin-resistant Staphylococcus aureus is raising global concern ...cdn clinicaltrialsProt_001.pdf

Cefazolin plus ertapenem has been reported in an 11-patient case series of persistent MSSA bacteremia lasting 4-9 days despite prior therapy; 8 of 9 evaluable episodes cleared cultures within 24 hours after combination initiation. This is limited observational rescue evidence, not a standard first-line regimen, and persistent SAB should first prompt aggressive investigation for inadequate source control or an occult endovascular focus. NEJM+1NEJMCefazolin plus Ertapenem for Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia | NEJM Cliniciancdn clinicaltrialsProt_001.pdf